An Optically Induced Dielectrophoresis (ODEP)-Based Microfluidic System for the Isolation of High-Purity CD45neg/EpCAMneg Cells from the Blood Samples of Cancer Patients—Demonstration and Initial Exploration of the Clinical Significance of These Cells

Circulating tumour cells (CTCs) in blood circulation play an important role in cancer metastasis. CTCs are generally defined as the cells in circulating blood expressing the surface antigen EpCAM (epithelial cell adhesion molecule). Nevertheless, CTCs with a highly metastatic nature might undergo an epithelial-to-mesenchymal transition (EMT), after which their EpCAM expression is downregulated. In current CTC-related studies, however, these clinically important CTCs with high relevance to cancer metastasis could be missed due to the use of the conventional CTC isolation methodologies. To precisely explore the clinical significance of these cells (i.e., CD45neg/EpCAMneg cells), the high-purity isolation of these cells from blood samples is required. To achieve this isolation, the integration of fluorescence microscopic imaging and optically induced dielectrophoresis (ODEP)-based cell manipulation in a microfluidic system was proposed. In this study, an ODEP microfluidic system was developed. The optimal ODEP operating conditions and the performance of live CD45neg/EpCAMneg cell isolation were evaluated. The results demonstrated that the proposed system was capable of isolating live CD45neg/EpCAMneg cells with a purity as high as 100%, which is greater than the purity attainable using the existing techniques for similar tasks. As a demonstration case, the cancer-related gene expression of CD45neg/EpCAMneg cells isolated from the blood samples of healthy donors and cancer patients was successfully compared. The initial results indicate that the CD45neg/EpCAMneg nucleated cell population in the blood samples of cancer patients might contain cancer-related cells, particularly EMT-transformed CTCs, as suggested by the high detection rate of vimentin gene expression. Overall, this study presents an ODEP microfluidic system capable of simply and effectively isolating a specific, rare cell species from a cell mixture.

[1]  M. Dietel,et al.  Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites , 1996, Histopathology.

[2]  R. Weinberg,et al.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.

[3]  D. Krag,et al.  Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients , 2008, Breast Cancer Research.

[4]  A. Satelli,et al.  Vimentin in cancer and its potential as a molecular target for cancer therapy , 2011, Cellular and Molecular Life Sciences.

[5]  C. Lindsay,et al.  Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer , 2016, BMC Cancer.

[6]  Min-Hsien Wu,et al.  A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal Cancer , 2018, International journal of biological sciences.

[7]  Song-Bin Huang,et al.  Label-free Live and Dead Cell Separation Method Using a High-Efficiency Optically-Induced Dielectrophoretic (ODEP) Force-based Microfluidic Platform , 2014 .

[8]  K. Pantel,et al.  A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells , 2016, International journal of cancer.

[9]  Gwo-Bin Lee,et al.  Continuous nucleus extraction by optically-induced cell lysis on a batch-type microfluidic platform. , 2016, Lab on a chip.

[10]  Mehmet Toner,et al.  Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells , 2013, Science Translational Medicine.

[11]  Yanjian Liao,et al.  Research Progress on Microfluidic Chip of Cell Separation Based on Dielectrophoresis , 2015 .

[12]  Gang Li,et al.  A microfluidic chip integrated with a high-density PDMS-based microfiltration membrane for rapid isolation and detection of circulating tumor cells. , 2015, Biosensors & bioelectronics.

[13]  M.C. Wu,et al.  Optically Controlled Cell Discrimination and Trapping Using Optoelectronic Tweezers , 2007, IEEE Journal of Selected Topics in Quantum Electronics.

[14]  Xingzhong Zhao,et al.  Engineered red blood cells for capturing circulating tumor cells with high performance. , 2018, Nanoscale.

[15]  Shuang Hou,et al.  Nanostructure Embedded Microchips for Detection, Isolation, and Characterization of Circulating Tumor Cells , 2014, Accounts of chemical research.

[16]  L. Ellis,et al.  Epithelial–Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression , 2014, Clinical Cancer Research.

[17]  Lianqing Liu,et al.  Programmable micrometer-sized motor array based on live cells. , 2017, Lab on a Chip.

[18]  Yan-wu Zhang,et al.  Role of Circulating Tumor Cell (CTC) Monitoring in Evaluating Prognosis of Triple-Negative Breast Cancer Patients in China , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[19]  H. Jung,et al.  Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). , 2011, Lab on a chip.

[20]  S. Agelaki,et al.  Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients , 2011, Breast Cancer Research.

[21]  Tony J. Pircher,et al.  Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood , 2011, Journal of oncology.

[22]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[23]  K. Svoboda,et al.  Biological applications of optical forces. , 1994, Annual review of biophysics and biomolecular structure.

[24]  H. Tseng,et al.  Capture and Stimulated Release of Circulating Tumor Cells on Polymer‐Grafted Silicon Nanostructures , 2013, Advanced materials.

[25]  R. Crystal,et al.  A SNAIL1–SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial–mesenchymal transition , 2009, Nature Cell Biology.

[26]  R. Pethig.  Review article-dielectrophoresis: status of the theory, technology, and applications. , 2010, Biomicrofluidics.

[27]  S Miltenyi,et al.  Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. , 1998, Experimental hematology.

[28]  J. Kendall,et al.  Rapid Phenotypic and Genomic Change in Response to Therapeutic Pressure in Prostate Cancer Inferred by High Content Analysis of Single Circulating Tumor Cells , 2014, PloS one.

[29]  Glenn Heller,et al.  Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer , 2007, Clinical Cancer Research.

[30]  Stefan Sleijfer,et al.  Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. , 2009, Cancer treatment reviews.

[31]  Ping-Hei Chen,et al.  Optically-induced-dielectrophoresis (ODEP)-based cell manipulation in a microfluidic system for high-purity isolation of integral circulating tumor cell (CTC) clusters based on their size characteristics , 2018 .

[32]  T. Teknos,et al.  Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. , 2013, Oral oncology.

[33]  J. Cameron,et al.  Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma , 2016, Annals of surgery.

[34]  B. Ramaswamy,et al.  Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients , 2014, Breast Cancer Research.

[35]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.

[36]  Steven L Neale,et al.  Trap profiles of projector based optoelectronic tweezers (OET) with HeLa cells. , 2009, Optics express.

[37]  Gwo-Bin Lee,et al.  A microfluidic platform for manipulation and separation of oil-in-water emulsion droplets using optically induced dielectrophoresis , 2010 .

[38]  T. Laurell,et al.  Continuous flow microfluidic separation and processing of rare cells and bioparticles found in blood - A review. , 2017, Analytica chimica acta.

[39]  Hung-Ming Wang,et al.  Isolation of label-free and viable circulating tumour cells (CTCs) from blood samples of cancer patients through a two-step process: negative selection-type immunomagnetic beads and spheroid cell culture-based cell isolation , 2017 .

[40]  I. Thompson,et al.  Single‐cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT‐related genes in metastatic prostate cancer , 2013, The Prostate.

[41]  Min-Hsien Wu,et al.  A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[42]  P. Sethu,et al.  Review: Microfluidics technologies for blood-based cancer liquid biopsies. , 2018, Analytica Chimica Acta.

[43]  K. Schütze,et al.  Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. , 2000, The American journal of pathology.

[44]  Klaus Pantel,et al.  Biology, detection, and clinical implications of circulating tumor cells , 2014, EMBO molecular medicine.

[45]  Gwo-Bin Lee,et al.  An integrated cell counting and continuous cell lysis device using an optically induced electric field , 2010 .

[46]  S. Anant,et al.  Cancer Stem Cell Metabolism and Potential Therapeutic Targets , 2018, Front. Oncol..

[47]  Gwo-Bin Lee,et al.  High-purity and label-free isolation of circulating tumor cells (CTCs) in a microfluidic platform by using optically-induced-dielectrophoretic (ODEP) force. , 2013, Lab on a chip.

[48]  Caffiyar Mohamed Yousuff,et al.  Microfluidic Platform for Cell Isolation and Manipulation Based on Cell Properties , 2017, Micromachines.

[49]  David J. Beebe,et al.  Integration of Magnetic Bead-Based Cell Selection into Complex Isolations , 2018, ACS omega.

[50]  Ming C. Wu,et al.  Massively parallel manipulation of single cells and microparticles using optical images , 2005, Nature.

[51]  May Yin Lee,et al.  Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity , 2015, Nature.

[52]  Brigitte Rack,et al.  Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.

[53]  M.C. Wu,et al.  Dynamic Cell and Microparticle Control via Optoelectronic Tweezers , 2007, Journal of Microelectromechanical Systems.

[54]  Bin-Da Chan,et al.  Circulating tumor cell detection using a parallel flow micro-aperture chip system. , 2015, Lab on a chip.

[55]  Min-Hsien Wu,et al.  The utilization of optically-induced-dielectrophoresis (ODEP)-based virtual cell filters in a microfluidic system for continuous isolation and purification of circulating tumour cells (CTCs) based on their size characteristics , 2017 .

[56]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[57]  K. Isselbacher,et al.  Isolation of circulating tumor cells using a microvortex-generating herringbone-chip , 2010, Proceedings of the National Academy of Sciences.

[58]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[59]  Hung-Ming Wang,et al.  Application of optically-induced-dielectrophoresis in microfluidic system for purification of circulating tumour cells for gene expression analysis- Cancer cell line model , 2016, Scientific Reports.

[60]  Kyung-A Hyun,et al.  Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs). , 2015, Biosensors & bioelectronics.

[61]  Yi-Wei Chen,et al.  Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. , 2009, Biochemical and biophysical research communications.